{"id":"W3028983586","doi":"10.1200/jco.2021.39.3_suppl.tps148","title":"Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer:NRG-GI005 (COBRA).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Medicine; Oncology; Internal medicine; FOLFOX; Colorectal cancer; Clinical endpoint; Chemotherapy; Adjuvant; Oxaliplatin; Stage (stratigraphy); Prospective cohort study; Biomarker; Cancer; Clinical trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003215171,0.002000397,0.001986506,0.0006080464,0.000374739,0.001062884,0.001618447,0.002185455,0.005467163],"category_scores_gemma":[0.001762105,0.0007583578,0.001360416,0.0006567113,0.001416037,0.0007759594,0.0006332998,0.00352674,0.001648519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001302588,"about_ca_system_score_gemma":0.003037836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002084381,"about_ca_topic_score_gemma":0.004672555,"domain_scores_codex":[0.9991409,0.0005300608,0.00002485687,0.0001059366,0.00006826835,0.0001299727],"domain_scores_gemma":[0.9985519,0.0002711315,0.0003374492,0.0001456111,0.0001004482,0.0005934144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8672488,0.04632356,0.01082544,0.0005895867,0.0006991867,0.0001340086,0.0001420606,0.0023918,0.01271814,0.0001835064,0.004843199,0.05390073],"study_design_scores_gemma":[0.6447974,0.3407837,0.009930938,0.0000407187,0.0003560472,0.0001186473,0.00003811694,0.001225433,0.001298329,0.0001194577,0.001270697,0.00002040891],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859715,0.002058893,0.0008049163,0.001264995,0.0001435105,0.005427499,0.002276644,0.0002244053,0.00182756],"genre_scores_gemma":[0.9719516,0.00209172,0.004125093,0.002184352,0.0002391635,0.008919749,0.006371326,0.00007902594,0.004037989],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005467163,"threshold_uncertainty_score":0.01828951,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03798842570987553,"score_gpt":0.4069943381514742,"score_spread":0.3690059124415986,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}